Rainbow Childrens Medicare Share Price Target 2027: 14.1% Upside to Rs 1,448, Bull Rs 1,754

Rainbow Childrens Medicare share price Rs 1,268.90 (5 November 2026). Base target Rs 1,448, bull Rs 1,754, downside risk Rs 1,023. PE 43.52. 52W range Rs 1,084.00 to Rs 1,610.00.

Investors weighing a Rainbow Childrens Medicare target price for 2027 should start with where the stock sits today. At Rs 1,268.90 on 5 November 2026, it is 21.2% below its 52-week high of Rs 1,610.00 and 17.1% above its 52-week low of Rs 1,084.00. That range spans 49% from low to high, so the entry point matters as much as the Rainbow Childrens Medicare price forecast itself.

This article builds the Rainbow Childrens Medicare share price target from reported numbers only: five years of annual results, the last five quarters, the latest shareholding pattern and current valuation ratios from company filings and exchange data. Each scenario states its assumptions, so you can trace how the base case, the bull case and the downside risk level were reached and test them against your own view.

Click Here – Get Free Investment Predictions

Rainbow Childrens Medicare Stock Analysis: Company Overview and Key Stats

Rainbow Childrens Medicare (NSE: RAINBOW) has a market capitalisation of Rs 12,990 crore. In FY26 it reported revenue of Rs 1,747 crore and net profit of Rs 281.54 crore. The table collects the figures the Rainbow Childrens Medicare share price target is built on.

Metric	Value
Company	Rainbow Childrens Medicare
NSE Ticker	RAINBOW
CMP (5 November 2026)	Rs 1,268.90
52-Week High	Rs 1,610.00
52-Week Low	Rs 1,084.00
Market Cap	Rs 12,990 crore
PE Ratio (TTM)	43.52
Industry PE	62.46
Price to Book	7.58
Return on Equity	17.05%
Debt to Equity	0.56
EPS (TTM)	Rs 29.39
Dividend Yield	0.27%
12-Month Base Target	Rs 1,448
Bull Case	Rs 1,754
Downside Risk Level (not a target)	Rs 1,023

Why Is Rainbow Childrens Medicare Share Price Target Set at Rs 1,448 for 2027?

The arithmetic is short. Trailing EPS of Rs 29.39 grown for one year gives a forward EPS estimate of Rs 33.28, and multiplying it by the unchanged PE of 43.52 gives the Rs 1,448 base-case Rainbow Childrens Medicare stock target. The bull case adds faster earnings growth and a higher multiple, while the downside risk level assumes flat earnings and a lower multiple.

Earnings Growth Behind the Rainbow Childrens Medicare Target Price: Five Years of Results

Rainbow Childrens Medicare grew revenue from Rs 992.70 crore in FY22 to Rs 1,747 crore in FY26, a compound annual growth rate of 15.2%. Net profit grew faster, from Rs 138.67 crore to Rs 281.54 crore (19.4% a year), which shows margin gains did part of the work and not just higher sales.

Financial Year	Revenue (Rs Cr)	Net Profit (Rs Cr)	EPS (Rs)	Dividend per Share (Rs)
FY22	992.70	138.67	14.45	2.00
FY23	1,204.44	212.38	20.89	3.00
FY24	1,333.96	218.29	21.38	3.00
FY25	1,566.87	244.23	23.84	3.00
FY26	1,746.87	281.54	27.41	3.50

FY26 revenue growth was 11.5%, slower than the four-year average of 15.2%, and net profit moved up 15.3%. EPS rose from Rs 21.38 in FY24 to Rs 27.41 in FY26. The FY27 outlook depends on whether that EPS estimate keeps compounding.

Margins and the Latest Quarter

Rainbow Childrens Medicare converted 16.1% of FY26 revenue into net profit, against 15.6% in FY25, within a five-year range of 14.0% to 17.6%. EBITDA margin was 33.6% in FY26 versus 34.5% in FY25.

In the September 2026 quarter, revenue was Rs 556.15 crore, up 22.8% from the same quarter a year earlier, while net profit of Rs 83.89 crore was up 10.9%. EBITDA came in at Rs 178.11 crore, up 13.4% year on year. The next quarterly result is the first test of whether the earnings assumption holds.

Balance Sheet and Cash Flow

Debt to equity stands at 0.56, and shareholders’ equity grew from Rs 606.26 crore in FY22 to Rs 1,664 crore in FY26. Operating cash flow in FY26 was Rs 419.66 crore against capital expenditure of Rs 216.46 crore, leaving free cash flow of Rs 203.20 crore, or 1.6% of the current market capitalisation. In FY25 free cash flow was Rs 249.99 crore.

Valuation Check for the Rainbow Childrens Medicare Stock Target: PE, Price to Book and ROE

At a PE of 43.52 against an industry PE of 62.46, Rainbow Childrens Medicare trades at a discount to its industry. Price to book is 7.58 on a book value of Rs 168.76 per share, and return on equity is 17.05%. A PE of 43.52 equals an earnings yield of 2.3%, and the FY26 dividend of Rs 3.50 per share gives a yield of 0.27%.

Shareholding Pattern and Institutional Holding

Promoters held 49.83% of Rainbow Childrens Medicare in September 2026, and promoter holding has stayed near 49.83% since September 2025. Foreign institutional investors (FII) held 14.66% and domestic institutions (DII) held 23.28%, which puts total institutional holding at 37.94%. FII holding fell from 21.85% in September 2025 to 14.66% in September 2026. Public shareholders own the remaining 12.23%. A meaningful institutional holding adds a layer of research coverage and trading depth.

Rainbow Childrens Medicare Share Price Targets for the Short Term and 12 Months

Short Term Rainbow Childrens Medicare Stock Target Levels: Technical Setup

At Rs 1,268.90 on 5 November 2026, Rainbow Childrens Medicare trades below its 50-day simple moving average of Rs 1,334.97 and below its 200-day exponential moving average of Rs 1,353.70. The 14-day RSI reads 54.8, which is neutral territory, and the MACD line sits above its signal line. The nearest resistance level is Rs 1,334.97 (50-day simple moving average) and the nearest support is Rs 1,084.00 (52-week low). A sustained move above Rs 1,334.97 would improve the short-term setup, while a close below Rs 1,084.00 would shift attention to the next support.

12 Month Rainbow Childrens Medicare Target Price for 2027

The 12-month target of Rs 1,448 means a move of 14.1% up from Rs 1,268.90 over the next 12 months. It would still leave the stock 10.1% below its 52-week high of Rs 1,610.00. Anyone checking the Rainbow Childrens Medicare share price target against their own view should focus on two inputs: the EPS estimate and the PE multiple.

How EPS Growth and PE Multiple Change the Rainbow Childrens Medicare Target Price

EPS Growth	PE 34.82	PE 43.52	PE 50.05
0.0% (EPS Rs 29.39)	Rs 1,023	Rs 1,279	Rs 1,471
13.2% (EPS Rs 33.28)	Rs 1,159	Rs 1,448	Rs 1,666
19.2% (EPS Rs 35.04)	Rs 1,220	Rs 1,525	Rs 1,754

Each cell multiplies the forward EPS estimate by the PE shown. Reading across a row shows what a de-rating or re-rating does to the Rainbow Childrens Medicare price forecast, and reading down a column shows what earnings growth is worth at a fixed multiple.

Bull Case and Downside Risk for Rainbow Childrens Medicare Stock Target in 2027

Bull Case Rs 1,754

The bull case Rainbow Childrens Medicare price target needs EPS growth of 19.2%, which lifts forward EPS to Rs 35.04, and a PE multiple that rises 15% to 50.05. That gives Rs 1,754, 38.2% above the current price and above the 52-week high of Rs 1,610.00, so the stock would have to set a fresh 52-week high.

Downside Risk Level Rs 1,023

The downside risk level is not a target. It assumes EPS stays flat at Rs 29.39 and the PE falls 20% to 34.82. That gives Rs 1,023, 19.4% below the current price and below the 52-week low of Rs 1,084.00.

Scenario	EPS Growth	PE Multiple	Price (Rs)	Change vs CMP
Bull Case	19.2%	50.05	Rs 1,754	+38.2%
Base Case	13.2%	43.52	Rs 1,448	+14.1%
Downside Risk	0.0%	34.82	Rs 1,023	-19.4%

Key Risks to the Rainbow Childrens Medicare Target Price for 2027

Growth Slowdown Risk for the Rainbow Childrens Medicare Price Target

Revenue in the September 2026 quarter was up 22.8% year on year, and FY26 revenue growth was 11.5%. If growth slows from here, the EPS estimate behind the Rainbow Childrens Medicare stock target will need revising.

Liquidity and Size Risk

Rainbow Childrens Medicare has a market capitalisation of Rs 12,990 crore. Institutional holding is 37.94%, and promoters hold 49.83%. Stocks of this size are usually liquid, though exits can take longer than entries when the market is falling.

Valuation and Margin Risk

Net margin was 16.1% in FY26, and a squeeze from higher costs or weaker pricing would hit earnings first. At a PE of 43.52 versus an industry PE of 62.46, a de-rating toward the downside-risk PE of 34.82 would cut the price even if earnings hold.

Market and Technical Risk

Technical indicators add short-term risk: the 14-day RSI is 54.8 and the MACD sits above its signal line. A broad fall in the Nifty 50 or the Sensex can override company fundamentals for weeks at a time. That applies to any Rainbow Childrens Medicare stock target, however carefully it is built.

How to Invest in Rainbow Childrens Medicare

Start with the live price and volume. Any Rainbow Childrens Medicare share price target is only as current as the data behind it, and the data here is as of 5 November 2026, so refresh the Rs 1,268.90 price before acting on any level.

Next, review the fundamentals yourself. The Univest Screener lets you check Rainbow Childrens Medicare’s PE, ROE, debt and shareholding in one place.

Check Rainbow Childrens Medicare fundamentals on the Univest Screener

Then compare the three Rainbow Childrens Medicare target price scenarios with your own view. If you expect EPS growth below 13.2%, the base case is too optimistic for you; if you expect more, the bull case deserves weight.

Decide your position size and exit levels before you buy. The support and resistance levels above can serve as reference points, but they are not recommendations.

Finally, place the order through a SEBI-registered broker or the Univest app, and review the position after each quarterly result. Consult a SEBI-registered advisor if you are unsure.

Download the Univest iOS App or Univest Android App to track Rainbow Childrens Medicare live price and get daily stock recommendations.

Conclusion

The Rainbow Childrens Medicare share price target for 2027 is Rs 1,448 in the base case, with Rs 1,754 as the bull case. The support for that view is arithmetic you can check: EPS grew 13.2% a year over FY24 to FY26, and the stock trades at a PE of 43.52. The risks are equally concrete, including a valuation that can de-rate even when earnings hold and a downside scenario that cuts the price 19% if earnings stall. Use these numbers as a framework, check them against the latest filings, and size any position to your own risk appetite.

FAQs on Rainbow Childrens Medicare Share Price Target 2027

What is the Rainbow Childrens Medicare share price target for 2027?

Ans. The base-case Rainbow Childrens Medicare share price target for 2027 is Rs 1,448, which is 14.1% above the price of Rs 1,268.90 on 5 November 2026. The bull case is Rs 1,754 and the downside risk level, which is not a target, is Rs 1,023. All three come from one method: forward EPS multiplied by a PE multiple, using only reported results. They are model estimates and not guaranteed outcomes, and the next quarterly result is the first check on the EPS assumption.

What is the Rainbow Childrens Medicare share price today?

Ans. As of 5 November 2026, 11:30 AM IST, Rainbow Childrens Medicare (NSE: RAINBOW) trades at Rs 1,268.90, down 0.84% on the day. That is 21.2% below the 52-week high of Rs 1,610.00 and 17.1% above the 52-week low of Rs 1,084.00. The market capitalisation of Rs 12,990 crore places it among mid-cap stocks. Prices change through the trading session, so check the live quote before acting on any level in this article.

Is Rainbow Childrens Medicare a buy or sell at the current price?

Ans. The data points both ways. On the positive side, EPS has grown 13.2% a year over FY24 to FY26 and the base case implies 14.1% upside; on the cautious side, the valuation can de-rate even when earnings hold, and the downside risk level of Rs 1,023 is 19% below the current price. Whether Rainbow Childrens Medicare fits your portfolio depends on your time horizon, position size and risk appetite. Consult a SEBI-registered advisor before investing, as this article is not investment advice.

What are the bull case target and downside risk level for Rainbow Childrens Medicare shares?

Ans. The bull case in the Rainbow Childrens Medicare share price target for 2027 is Rs 1,754, which assumes 19.2% EPS growth and a PE of 50.05, a 15% re-rating from today’s multiple. That is 38.2% above the current price and above the 52-week high of Rs 1,610.00, so the stock would have to set a fresh 52-week high. The downside risk level is Rs 1,023, which assumes flat EPS and a PE of 34.82, 20% lower than today. It sits 19.4% below the current price and below the 52-week low of Rs 1,084.00, and it marks a risk to watch, not a target.

What are the main risks to the Rainbow Childrens Medicare price target?

Ans. Four risks matter most for the Rainbow Childrens Medicare share price target: slower revenue or profit growth, a PE de-rating, thin liquidity or size risk, and weakness in the broader market. With a market capitalisation of Rs 12,990 crore, the stock is usually liquid, though exits can take longer than entries in a falling market. A fall to the downside-risk PE of 34.82 would cut the price even if earnings hold.

What is the PE ratio of Rainbow Childrens Medicare and how does it compare with the industry?

Ans. The PE ratio of Rainbow Childrens Medicare is 43.52, against an industry PE of 62.46, which is a discount to the industry. Price to book is 7.58 and return on equity is 17.05%, and the PE equals an earnings yield of 2.3%. The base case holds the PE unchanged, so the Rainbow Childrens Medicare share price target moves only with earnings, while the bull and downside scenarios change the multiple by +15% and -20%.

Who owns Rainbow Childrens Medicare, and what is the promoter holding?

Ans. Promoters held 49.83% of Rainbow Childrens Medicare in September 2026. FII held 14.66%, DII held 23.28% and the public held 12.23%. Together the two institutional groups hold 37.94%. Shareholding is filed every quarter, so it is worth rechecking after each result.

What were Rainbow Childrens Medicare’s latest quarterly results?

Ans. In the September 2026 quarter, Rainbow Childrens Medicare reported revenue of Rs 556.15 crore (up 22.8% year on year) and net profit of Rs 83.89 crore (up 10.9%). For comparison, FY26 full-year revenue growth was 11.5% and net profit moved up 15.3%. Each new quarter either supports or weakens the EPS growth of 13.2% assumed in the base case.